Glutamine

Glutamine

SCHEMBL8764303

CC(=O)NC(CCC(N)=O)C(=O)O.NC(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.63
ALOX15 P16050 2/20 0.63
BLM P54132 2/20 0.63
PMP22 Q01453 1/20 0.63
NOD1 Q9Y239 6/20 0.48
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS2 P35354 1/20 0.46
THPO P40225 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GRM8 O00222 1/20 0.46
GRM6 O15303 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GSR P00390 1/20 0.46
CYP1A2 P05177 1/20 0.46
GRIK1 P39086 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamine SCHEMBL8764294 1.00 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL29150368 1.00 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
Glutamine SCHEMBL8764292 1.00 KMT2A (0.63) KMT2AALOX15BLMPMP22NOD1
SCHEMBL6445994 0.91 KMT2A (0.53) KMT2AALOX15BLMPMP22NOD1
SCHEMBL6445997 0.91 ALOX15 (0.53) KMT2AALOX15BLMPMP22KDM4E
SCHEMBL6026388 0.91 ALOX15 (0.53) KMT2AALOX15BLMPMP22KDM4E
SCHEMBL287578 0.91 ALOX15 (0.53) KMT2AALOX15BLMPMP22KDM4E
SCHEMBL287577 0.91 ALOX15 (0.53) KMT2AALOX15BLMPMP22KDM4E
Glutamine SCHEMBL29150372 0.90 NOD1 (0.55) KMT2AALOX15BLMPMP22NOD1
SCHEMBL147914 0.90 ALOX15 (0.52) KMT2AALOX15BLMPMP22KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0547099-B1 PRODUCT CONTAINING GROWTH FACTOR AND GLUTAMINE AND USE OF GROWTH FACTOR FOR THE TREATMENT OF INTESTINAL MUCOSA PHARMACIA & UPJOHN AB (SE) 1997-07-30 EP claimed